
Checkmate Pharmaceuticals (CMPI)
Order type
Buy in
Order amount
Est. shares
0 shares
Buy Checkmate Pharmaceuticals (CMPI) Stock
Start investing in Checkmate Pharmaceuticals (CMPI)
About Checkmate Pharmaceuticals (CMPI)
Market cap | $231.4M |
Today's volume | — |
Revenue (TTM) | — |
Avg. daily volume | 213.6K |
EBITDA (TTM) | — |
Open | — |
Price / earnings ratio | -3.60x |
Today's range | — |
Debt / equity | — |
52 week range | $2 - $10.5 |
5 year debt / equity | — |
Beta (LTM) | 1.03x |
Interest coverage | — |
Dividend & yield | $0.00 (0.00%) |
Current ratio | — |
Ex-dividend date | — |
Next earnings | May 12, 2022 |
Dividend payable date | — |
Checkmate Pharmaceuticals Stock News
View all



Frequently Asked Questions (FAQ)
How to buy CMPI stock on Public
- 1
Sign up for a brokerage account on Public
It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.
- 2
Add funds to your Public account
There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.
- 3
Choose how much you'd like to invest in CMPI stock
Navigate to the Explore page. Then, type CMPI into the search bar. When you see CMPI stock appear in the results, tap it to open up the purchase screen.
- 4
Manage your investments in one place
You can find your newly purchased CMPI stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.
Checkmate Pharmaceuticals Stock Earnings
The value each CMPI share was expected to gain vs. the value that each CMPI share actually gained.
Checkmate Pharmaceuticals (CMPI) reported Q4 2021 earnings per share (EPS) of -$0.62, beating estimates of -$0.74 by 16.22%. In the same quarter last year, Checkmate Pharmaceuticals's earnings per share (EPS) was $1.30. Checkmate Pharmaceuticals is expected to release next earnings on 05/12/2022, with an earnings per share (EPS) estimate of $0.